Two Sigma Advisers’s Urovant Sciences Ltd. UROV Stock Holding History

Two Sigma Advisers’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,100	Closed	-$195K	–	2783
2020 Q4	$195K	Buy	+12,100	New	+$150K	﹤0.01%	2181

Two Sigma Advisers's UROV Position: Q1 2021 in Review

Two Sigma Advisers sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 12,100 shares — an estimated $195K sold.

Two Sigma Advisers first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $195K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Two Sigma Advisers reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Two Sigma Advisers sold 12,100 Urovant Sciences Ltd. shares in Q1 2021, an estimated $195K.
Two Sigma Advisers first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Two Sigma Advisers's Urovant Sciences Ltd. position peaked at $195K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Two Sigma Advisers's 13F filing for Q1 2021, filed 17 May 2021.